Digitalis Glycosides Interactions

Both slow atrioventricular conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:acebutolol hydrochloride

Patients receiving digitalis should be observed carefully for development of cardiac arrhythmias.

Source: NLP:adrenalin (epinephrine)

Both slow atrioventricular conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:atenolol

Both drugs slow atrioventricular conduction and decrease heart rate; concomitant use increases bradycardia risk.

Source: NLP:atenolol and chlorthalidone

Patients may be at increased risk of arrhythmias due to hypokalemia induced by corticosteroids.

Source: NLP:betamethasone sodium phosphate and betamethasone acetate

Both slow AV conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:bisoprolol fumarate

Both digitalis and beta-blockers slow AV conduction and decrease heart rate. Concomitant use increases risk of bradycardia.

Source: NLP:bisoprolol fumarate and hydrochlorothiazide

Hypercalcemia may precipitate cardiac arrhythmias in patients on digitalis therapy; careful dosage determination required.

Source: NLP:calcitriol

Hypercalcemia resulting from calcitriol use may precipitate cardiac arrhythmias in digitalis-treated patients; dosage must be determined with care.

Source: NLP:calcitriol capsules 0.25 mcg

Digitalis glycosides and carvedilol both slow atrioventricular conduction and decrease heart rate, increasing bradycardia risk.

Source: NLP:carvedilol

Cholestyramine may delay or reduce digitalis absorption; discontinuance poses hazard if digitalis was titrated to maintenance level during cholestyramine use.

Source: NLP:cholestyramine

Cholestyramine may reduce digitalis absorption; discontinuance poses hazard if drug was titrated to maintenance level during concurrent use.

Source: NLP:cholestyramine powder for suspension

Cholestyramine may reduce digitalis absorption; discontinuance could pose hazard if drug was titrated to maintenance level during concurrent use.

Source: NLP:choleystyramine light

Potential for additive effects such as bradycardia and AV block. Caution is warranted.

Source: NLP:clonidine hydrochloride

Patients may be at risk of arrhythmias due to hypokalemia induced by corticosteroids.

Source: NLP:depo-medrol, lidocaine, isopropyl alcohol

Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia induced by dexamethasone.

Source: NLP:dexamethasone

Patients on digitalis glycosides may be at increased risk of arrhythmias due to dexamethasone-induced hypokalemia.

Source: NLP:dexamethasone intensol

Additive effects in prolonging AV conduction when used concomitantly with diltiazem hydrochloride.

Source: NLP:diltiazem hydrochloride

Doxercalciferol-induced hypercalcemia can potentiate the risk of digitalis toxicity. Monitor for signs and symptoms of digitalis toxicity.

Source: NLP:doxercalciferol

May increase possibility of arrhythmias when given with ephedrine. Carefully monitor patients on cardiac glycosides.

Source: NLP:ephedrine sulfate

Cardiac glycosides potentiate arrhythmogenic effects of epinephrine.

Source: NLP:epinephrine

Enhanced possibility of arrhythmias or digitalis toxicity associated with hypokalemia. Monitor serum potassium levels and use potassium supplements if necessary.

Source: NLP:fludrocortisone acetate

Patients on digitalis glycosides may be at increased risk of arrhythmias due to corticosteroid-induced hypokalemia.

Source: NLP:hydrocortisone sodium succinate

Both digitalis glycosides and labetalol slow atrioventricular conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:labetalol

Both digitalis glycosides and labetalol slow AV conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:labetalol hydrochloride

Therapeutic effects of digitalis glycosides may be reduced by levothyroxine. Serum digitalis glycoside levels may decrease when hypothyroid patient becomes euthyroid, necessitating dose increase.

Source: NLP:levothyroxine sodium anhydrous

Monitor toxicity when lidocaine is used in patients with digitalis toxicity accompanied by supraventricular arrhythmia and/or atrioventricular block.

Source: NLP:lidocaine hydrochloride

Patients on digitalis glycosides may be at increased risk of arrhythmias due to corticosteroid-induced hypokalemia.

Source: NLP:ammonia, lidocaine hydrochloride, triamcinolone acetonide, povidone-iodine

Patients may be at risk of arrhythmias due to hypokalemia caused by corticosteroids.

Source: NLP:methylprednisolone acetate

Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia from corticosteroid use.

Source: NLP:methylprednisolone sodium succinate

Diuretic-induced hypokalemia can increase myocardial sensitivity to digitalis, resulting in serious arrhythmias.

Source: NLP:metolazone

Digitalis glycosides slow atrioventricular conduction and decrease heart rate; concomitant use with metoprolol increases bradycardia risk.

Source: NLP:metoprolol succinate

Digitalis slows atrioventricular conduction and decreases heart rate; concomitant use with metoprolol increases risk of bradycardia.

Source: NLP:metoprolol succinate er tablets

Concomitant use increases risk of bradycardia due to additive negative chronotropic effects.

Source: NLP:metoprolol tartrate

Concomitant use with metoprolol can increase risk of bradycardia due to slowed atrioventricular conduction and decreased heart rate.

Source: NLP:metoprolol tartrate and hydrochlorothiazide

Both digitalis glycosides and nadolol slow atrioventricular conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:nadolol

Both slow atrioventricular conduction and decrease heart rate; concomitant use increases risk of bradycardia.

Source: NLP:nebivolol

Both slow atrioventricular conduction and decrease heart rate, increasing risk of bradycardia when used concomitantly.

Source: NLP:nebivolol hydrochloride

Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia from concurrent corticosteroid use.

Source: NLP:prednisolone sodium phosphate

Patients on digitalis glycosides are at increased risk of arrhythmias due to corticosteroid-induced hypokalemia.

Source: NLP:prednisone

Absorption of calcium-containing solution may increase digitalis effects and lead to serious or fatal cardiac arrhythmia.

Source: NLP:sodium chloride, soldium lactate, potassium chloride and calcium chloride

Patients may be at increased risk of arrhythmias due to hypokalemia induced by corticosteroids.

Source: NLP:triamcinolone acetonide

Concurrent use may induce hypokalemia and potentiate digitalis toxicity. Serum potassium levels should be closely monitored.

Source: NLP:amphotericin b

Concomitant use may have additive effects in prolonging atrioventricular conduction time.

Source: NLP:brimonidine tartrate and timolol maleate

Digitalis may influence serum electrolytes when used with chlorthalidone, requiring monitoring for warning signs of electrolyte imbalance.

Source: NLP:chlorthalidone

Monitor heart rate in patients receiving clonidine concomitantly with digitalis, which affects sinus node function or AV nodal conduction.

Source: NLP:clonidine

Monitor heart rate in patients receiving clonidine concomitantly with digitalis due to effects on sinus node function or AV nodal conduction.

Source: NLP:clonidine transdermal system

Patients on digitalis glycosides may be at increased risk of arrhythmias due to dexamethasone-induced hypokalemia.

Source: NLP:dexamethasone 1.5 mg

May have additive effects in prolonging atrioventricular conduction time.

Source: NLP:dorzolamide hydrochloride timolol maleate

May partially counteract the anticoagulant action of heparin. Careful monitoring recommended.

Source: NLP:heparin sodium

Serum digitalis levels may increase when hyperthyroid patients become euthyroid; reduced digitalis dosage may be needed.

Source: NLP:methimazole

Concomitant use increases risk of bradycardia due to combined negative chronotropic effects.

Source: NLP:metoprolol

Isolated reports of elevated digoxin levels with possible interaction. Monitor digoxin levels when initiating, adjusting, or discontinuing nifedipine.

Source: NLP:nifedipine

May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.

Source: NLP:potassium bicarbonate

Both agents slow atrioventricular conduction and decrease heart rate, increasing risk of bradycardia.

Source: NLP:propranolol hydrochloride

Serum digitalis levels may increase when hyperthyroid patients on stable digitalis therapy become euthyroid. A reduced dose of digitalis glycosides may be needed.

Source: NLP:propylthiouracil

Concomitant use may have additive effects in prolonging atrioventricular conduction time.

Source: NLP:timolol

May have additive effects in prolonging atrioventricular conduction time when used concomitantly with timolol.

Source: NLP:timolol hemihydrate

Concomitant use of timolol with digitalis may have additive effects in prolonging atrioventricular conduction time.

Source: NLP:timolol maleate

Concomitant use may have additive effects in prolonging atrioventricular conduction time.

Source: NLP:timolol maleate ophthalmic gel forming solution

Patients may be at increased risk of arrhythmias due to corticosteroid-induced hypokalemia.

Source: NLP:triamcinolone acetonide extended-release injectable suspension

Administered without adverse drug interaction in limited clinical experience.

Source: NLP:prazosin hydrochloride

Verapamil has been used concomitantly with digitalis without evidence of serious negative drug interactions.

Source: NLP:verapamil hydrochloride